A Study of Comparing Overall Improvement of Patients With Spondyloarthritis Treated With Jitongning Tablets and Placebo
Clinical trial NCT06000956 · RECRUITING
Trial details
- NCT number
- NCT06000956
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-11
- Primary completion
- 2026-12-01
- Enrollment
- 408
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.